Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
EV-to-OCF is calculated as enterprise value divided by its cash flow from operations. As of today, Hims & Hers Health's Enterprise Value is CHF5,999 Mil.
Hims & Hers Health's Cash Flow from Operations for the trailing twelve months (TTM) ended in Jun. 2026 was CHF209 Mil. Therefore, Hims & Hers Health's EV-to-OCF for today is 28.72.
The historical rank and industry rank for Hims & Hers Health's EV-to-OCF or its related term are showing as below:
XSWX:HIMS'
s EV-to-OCF Range Over the Past 10 Years
Min: -301.93 Med: 24.14 Max: 982.79
Current: 28.01
During the past 7 years, the highest EV-to-OCF of Hims & Hers Health was 982.79. The lowest was -301.93. And the median was 24.14.
XSWX:HIMS's EV-to-OCF is ranked worse than 77.31% of 1005
companies
in the Drug Manufacturers industry
Industry Median: 11
vs XSWX:HIMS: 28.01
EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Hims & Hers Health (XSWX:HIMS) EV-to-OCF Explanation
EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Hims & Hers Health's PE Ratio (TTM) for today is calculated as:
Hims & Hers Health's share price for today is CHF22.945.
Hims & Hers Health's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was CHF-0.499.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Cash Flow from Operations is an important financial metric because it represents the cash generated from operating activities at a company's disposal. Companies with a low EV-to-OCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Hims & Hers Health EV-to-OCF Related Terms
Hims & Hers Health EV-to-OCF Historical Data
* Premium members only.
The historical data trend for Hims & Hers Health's EV-to-OCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XSWX:HIMS vs LNTH, AMRX, LQDA: EV-to-OCF Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Hims & Hers Health's EV-to-OCF, along with its competitors' market caps and EV-to-OCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Hims & Hers Health EV-to-OCF vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Hims & Hers Health's EV-to-OCF distribution charts can be found below:
* The bar in red indicates where Hims & Hers Health's EV-to-OCF falls into.
Hims & Hers Health's current Enterprise Value is CHF5,999 Mil.
Hims & Hers Health's Cash Flow from Operations for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was CHF209 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Hims & Hers Health (XSWX:HIMS) has a EV-to-OCF of 28.72 as of Aug. 18, 2026. This is 19% above median its historical median of 24.14. According to the industry distribution chart, Hims & Hers Health ranks #777 out of 1005 companies in the Drug Manufacturers industry, placing it in the top 77.3%.
Is Hims & Hers Health's EV-to-OCF too high?
Hims & Hers Health's current EV-to-OCF of 28.72 is 19% above median its 10-year median of 24.14. The Drug Manufacturers industry median EV-to-OCF is 11.00. Hims & Hers Health's value of 28.72 is 161.1% above this industry median. Based on the distribution chart, Hims & Hers Health ranks #777 out of 1005 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Hims & Hers Health has a GF Score™ of 77/100, reflecting its overall financial health beyond just this single metric.
How does Hims & Hers Health's EV-to-OCF compare to LNTH and AMRX?
According to the Drug Manufacturers industry distribution chart, Hims & Hers Health ranks #777 out of 1005 companies for EV-to-OCF. This places Hims & Hers Health in the lower half of its industry. The industry median EV-to-OCF is 11.00. Hims & Hers Health's value of 28.72 is 161.1% above this benchmark. While the company's 10-year median is 24.14 vs. the industry median of 11.00, Hims & Hers Health has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-OCF for a Drug Manufacturers company?
The median EV-to-OCF among Drug Manufacturers companies is 11.00, based on 1,005 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-OCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-OCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Hims & Hers Health's current EV-to-OCF of 28.72 is 161.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-OCF mean?
A high EV-to-OCF can signal that a stock is expensive relative to its fundamentals. For the Drug Manufacturers industry, the median EV-to-OCF is 11.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Hims & Hers Health's current EV-to-OCF is 28.72, which is 19% above median its own 10-year median of 24.14. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Hims & Hers Health stock overvalued right now?
Hims & Hers Health (XSWX:HIMS) has a current EV-to-OCF of 28.72. The stock's GF Value™ is CHF33.96, compared to a current price of CHF22.95 — trading 32.4% below its estimated fair value. The current EV-to-OCF is 28.72, which is 19% above median its 10-year median of 24.14 and 161.1% above the Drug Manufacturers industry median of 11.00. Hims & Hers Health's overall GF Score™ is 77/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-OCF calculated?
EV-to-OCF is calculated from a company's financial statements. For Hims & Hers Health (XSWX:HIMS), the current EV-to-OCF is 28.72 as of Aug. 18, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Hims & Hers Health (XSWX:HIMS) Overvalued in 2026?
Based on GuruFocus' analysis, Hims & Hers Health stock appears to be undervalued.
The current stock price of CHF22.95 is trading 32.4% below its estimated GF Value™ of CHF33.96.
Key valuation signals for XSWX:HIMS:
EV-to-OCF: 28.72 (19% above median its 10-year median of 24.14)
GF Value™: CHF33.96 vs. price of CHF22.95 (32.4% below fair value)
Industry Position: 161.1% above the Drug Manufacturers median (#777 of 1005)
No single metric tells the full story. See the XSWX:HIMS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Hims & Hers, launched in 2017, is a telehealth platform that connects patients and healthcare providers to offer treatment options for specialties like erectile dysfunction, hair loss, skin care, mental health, and weight loss. Its offerings include generic, branded, and compounded prescription drugs as well as over-the-counter medicines, cosmetics, and supplements. The platform, which has more than 2 million subscribers, is available in all 50 states and certain European markets like the UK. It includes provider networks, electronic medical records, cloud pharmacy fulfillment, and personalization capabilities. Hims does not take insurance and only accepts payments directly from customers.
77GF Score
Get the complete analysis for XSWX:HIMS
EV-to-OCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XSWX:HIMS has been successfully added to your 
